In 2010, it was reported that the world-wide prevalence of individuals living with a stroke was approximately 33 million, with 17 million new strokes occurring every year. Additionally, it is estimated that 87% of these strokes are designated ischaemic strokes, with 30–40% having no identifiable aetiology on initial evaluation. For this reason, these strokes receive the designation of cryptogenic strokes or embolic strokes of undetermined source (ESUS).
Female athletes are 50% more likely than male athletes to have a sports-related concussion, according to a preliminary study released to be presented at the American Academy of Neurology’s 69th Annual Meeting (ANN; Boston, USA, April 22-28, 2017).
Stroke patients receiving clot-busting medications before arriving at the hospital have a lower risk for disability afterward, according to research presented at the American Stroke Association’s International Stroke Conference 2017 (ISC; 22–24 February, Houston, USA).
People who survive brain bleeds are at significantly higher risk of later developing depression and dementia, according to research presented at the American Stroke Association’s International Stroke Conference 2017 (ISC; 22–24 February, Houston, USA).
A new study published online by JAMA Neurology examines the long-term outcomes of patients with aggressive forms of multiple sclerosis who failed to respond to standard therapies and who underwent autologous hematopoietic stem cell transplantation using their own stem cells.
The latest study on hormone therapy and Alzheimer’s disease shows no relationship between taking the drugs and developing the disease years later. Some previous studies have shown that hormone therapy may increase the risk of the disease, while others have shown that it may reduce the risk. The new study was published online in Neurology.
The first study of its kind designed to test the effects of a diet on the decline of cognitive abilities among a large group of individuals 65 to 84 years who currently do not have cognitive impairment has begun.
In response to a growing body of evidence of the existence of “covert” brain injury to patients undergoing transcatheter aortic valve implantation (TAVI) and other cardiac procedures, The Neurologic Academic Research Consortium (NeuroARC) has announced the simultaneous publication of a consensus paper offering a new classification of neurologic outcomes and testing to better ensure the safety of cardiac procedures. The paper is available online, and will be published in the Journal of American College of Cardiology and a future issue of the European Heart Journal.
In 2016, Penumbra announced the launch of the ACE68 reperfusion catheter, part of the Penumbra System at the Society of NeuroInterventional Surgery 13th Annual Meeting (SNIS; 25–28 July, Boston, USA).
A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal of Neurointerventional Surgery (JNIS), the authors report that even in challenging complex bifurcation aneurysms they achieved good treatment results using the kissing-Y stenting technique.
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the procedural safety, as well as the economic and functional benefit, of early surgical removal of intracerebral haemorrhage using the BrainPath Approach compared to the medical management standard of care. The BrainPath Approach uses a combination of technologies, including the FDA-cleared NICO BrainPath (NICO Corporation) for non-disruptive access and NICO Myriad to achieve the goal of maximum clot evacuation.
A study published in the Journal of Anatomy has made a breakthrough in the examination of blood vessels in the brain, giving scientists a clearer understanding of how dementia, brain cancer and stroke can affect veins and capillaries in this organ.
BrainScope has announced the market release of its flagship Ahead 300 product, and will initiate a limited launch to a select group of thought leaders through its Centers of Excellence programme later in the first quarter. These institutions will represent a cross-section of market segments including Urgent Care Clinics, Concussion Clinics, Emergency Medicine Departments, and University and Professional Sports.
A new study has shown that older people who followed a “Mediterranean diet” retain more brain volume over a three-year period than those who have not followed the diet as closely. The research was published online in Neurology. Contrary to earlier studies, researchers also found no relation between the proportion of fish and meat consumed by participants, and changes in the brain.
Amnis Therapeutics has received approval to perform a first-in-human clinical trial with its neuro thrombectomy device, the Golden Retriever. The approval was received from the Karolinska Institute (Stockholm, Sweden).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos